openPR Logo
Press release

Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market to Exhibit a Remarkable CAGR of 9.10% by 2030, Size, Share, Trends, Key Drivers, Demand, Opportunity Analysis and Competitive Outlook

Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market

Data Bridge Market Research analyses that the global non-peptide drugs of angiotensin II receptor antagonist market, which was USD 177,430.32million in 2022, is expected to reach USD 325,986.34 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period 2023-2030.

Non-peptide drugs of Angiotensin II receptor antagonists (also known as Angiotensin II receptor blockers or ARBs) are a class of medications used to treat conditions like hypertension (high blood pressure) and certain cardiovascular conditions. They work by blocking the action of angiotensin II, a hormone that narrows blood vessels and raises blood pressure. By doing so, ARBs help relax blood vessels, lower blood pressure, and reduce the workload on the heart.

Browse More About This Research Report @
https://www.databridgemarketresearch.com/reports/global-non-peptide-drugs-of-angiotensin-ii-receptor-antagonist-market

Some of the major players operating in the Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market are Novartis (Switzerland), Daiichi Sankyo (Japan), Takeda Pharmaceutical Company (Japan), Boehringer Ingelheim  (Germany), AstraZeneca (U.K.), Pfizer (U.S.), Sanofi (France), Merck & Co. (U.S.), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), GlaxoSmithKline (GSK) (United Kingdom), Bayer (Germany), Mylan (United States), Sun Pharmaceutical Industries (India), Torrent Pharmaceuticals (India), Zydus Cadila (India), Cipla  (India), Glenmark Pharmaceuticals (India), Mitsubishi Tanabe Pharma (Japan), Ipca Laboratories (India) among others.

Competitive Landscape and Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Share Analysis :

Global non-peptide drugs of angiotensin II receptor antagonist market competitive landscape provide details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global non-peptide drugs of angiotensin II receptor antagonist market.

Browse Trending Reports:

https://dbmrblogs.blogspot.com/2024/07/homeopathy-products-market-trends.html

https://dbmrblogs.blogspot.com/2024/08/dna-fragmentation-technique-market-size.html

https://dbmrblogs.blogspot.com/2024/08/endotoxin-detecting-reagents-market.html

https://dbmrblogs.blogspot.com/2024/08/fiberglass-fabric-market-industry.html

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Contact Us: -
Data Bridge Market Research
Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market to Exhibit a Remarkable CAGR of 9.10% by 2030, Size, Share, Trends, Key Drivers, Demand, Opportunity Analysis and Competitive Outlook here

News-ID: 3648310 • Views:

More Releases from Data Bridge Market Research

Single Cell Analysis Market to Observe Prominent CAGR of 15.60% by 2031, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Single Cell Analysis Market to Observe Prominent CAGR of 15.60% by 2031, Size, S …
Single cell analysis market size was valued at USD 4.14 billion in 2023 and is projected to reach USD 13.21 billion by 2031, with a CAGR of 15.60% during the forecast period of 2024 to 2031. Market Definition: Single-cell analysis is the study of genomes, transcriptomics, proteomics, and metabolomics at the single-cell level, and it is used in cancer research and the treatment of a variety of chronic and infectious disorders. It
Fire Protection System Market Size, Share, and Trends Analysis Report to Observe Prominent CAGR of 7.98% by 2030, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Fire Protection System Market Size, Share, and Trends Analysis Report to Observe …
Fire protection system market was valued at USD 69.66 billion in 2022 and is expected to reach USD 128.24 billion by 2030, registering a CAGR of 7.98% during the forecast period of 2023-2030. Installation and Design Services accounts for the largest service segment in the respective market owing to the high preference due to the subject-matter expertise offered by vendors. Market Definition: Fire protection systems are chiefly used to control, detect and
Agriculture Micronutrients Market to Observe Prominent CAGR of 9.30% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Agriculture Micronutrients Market to Observe Prominent CAGR of 9.30% by 2029, Si …
Data Bridge Market Research analyses that the agriculture micronutrients market which was growing at a value of 4.90 billion in 2021 and is expected to reach the value of USD 9.98 billion by 2029, at a CAGR of 9.30% during the forecast period. Market Definition: Agricultural micronutrients are essential mineral elements that plants use in small amounts, such as zinc (Zn), copper (Cu), manganese (Mn), iron (Fe), boron (B), and molybdenum
Pallet Pooling Market: Overview, Scope, Trends, and Growth Factors 2028
Pallet Pooling Market: Overview, Scope, Trends, and Growth Factors 2028
The pallet pooling market involves the shared use of pallets by multiple users or companies to transport and store goods efficiently. Instead of purchasing pallets outright, companies lease them from pallet pooling providers, ensuring consistent quality and availability. Once used, the pallets are collected, inspected, and redistributed to other users in the pool. This approach streamlines logistics, minimizes pallet waste, and reduces costs by improving the flow of goods throughout

All 5 Releases


More Releases for Angiotensin

Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report
Angiotensin II Receptor Blocker (ARBs) API Market To Upscale Amidst Technologica …
The professional intelligence report presents a comprehensive evaluation of various factors that may influence the future performance of the Global Angiotensin II Receptor Blocker (ARBs) API Market during the forecast period of 2021 to 2027. It highlights a host of interlinked factors that may create promising growth opportunities in the global Angiotensin II Receptor Blocker (ARBs) API market in coming years. It also provides holistic perspective regarding different trends that
Angiotensin Modulators Market 2020 Clinical Survey Report to 2026
Angiotensin Modulators -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Angiotensin Modulators Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has
Angiotensin Receptor Antagonists Market: The 2020-2030 Market and Growth Factor …
The study of Angiotensin Receptor Antagonists Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc.
Type 2 Angiotensin II Receptor Global Market Research Report 2025
Type 2 Angiotensin II Receptor Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/type-2-angiotensin-ii-receptor-market/80995 The report firstly introduced the Type 2 Angiotensin II
Angiotensin Converting Enzyme Inhibitors Market to Develop Rapidly by 2025
Angiotensin converting enzyme inhibitors are a group of drugs used for the treatment of heart failure, high blood pressure (hypertension), or decrease complications of myocardial infarction (heart attack). These drugs are also useful in slowing down kidney disease progression in patients with chronic kidney disease or kidney disease in diabetic patients. The mechanism of action of angiotensin converting enzyme inhibitors is to decrease the amount of angiotensin II produced. Angiotensin